Raquel R. D.
- Country
- Spain
- Department
- Dermatology
Research Overview
- Efficacy and Safety of Zasocitinib in Pediatric Participants with Moderate-to-Severe Plaque Psoriasis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
- Efficacy and Safety Evaluation of JNJ-77242113 Versus Placebo and Deucravacitinib in Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 214 of 393 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in treating severe dermatological disorders, with particular emphasis on chronic inflammatory skin conditions.
- Plaque Psoriasis
- Hidradenitis Suppurativa
- Acne Vulgaris
- Prurigo Nodularis
The investigator shows particular interest in both adult and pediatric manifestations of these conditions.
Treatment Approaches
The investigator focuses on evaluating novel therapeutic interventions for inflammatory skin diseases, including both systemic and topical treatments.
- Biological Therapies
- Novel Topical Medications
- Long-term Treatment Solutions
- Targeted Immunotherapy
Their work encompasses both short-term efficacy assessment and long-term safety monitoring.
Special Population Focus
The investigator demonstrates expertise in treating specific patient populations and specialized manifestations of skin conditions.
- Pediatric Dermatology
- Moderate to Severe Disease States
- Special Area Manifestations
- Treatment-Resistant Cases
Their research includes specialized approaches for different age groups and disease severities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.